Department of Chemistry and Biochemistry and California NanoSystems Institute, University of California, Los Angeles , 607 Charles E. Young Drive East, Los Angeles, California 90095, United States.
J Am Chem Soc. 2017 Jan 25;139(3):1145-1154. doi: 10.1021/jacs.6b10776. Epub 2017 Jan 12.
Many proteins, especially those used as therapeutics, are unstable to storage and shipping temperatures, leading to increased costs in research and industry. Therefore, the design and synthesis of novel stabilizers is an important area of investigation. Herein we report new degradable polymers that stabilize proteins to environmental stressors such as refrigeration and elevated temperature. Specifically, polycaprolactones with different pendant groups were synthesized and surveyed for their ability to stabilize an important therapeutic protein to storage and shipping conditions. Ring-opening polymerization (ROP) of an allyl-substituted caprolactone monomer was carried out using the organocatalyst 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD) to yield a well-defined, alkene-substituted degradable polymer, which was used as a common backbone to control for the degree of polymerization. Relevant side chains such as trehalose, lactose, glucose, carboxybetaine, and oligo(ethylene glycol) were installed via postpolymerization thiol-ene reactions. These degradable polymers were then employed as excipients for the stabilization of the therapeutic protein granulocyte colony-stimulating factor (G-CSF) against storage at 4 °C and shipping temperatures of 60 °C. The best stabilization was observed using the trehalose- and zwitterion- substituted polyesters. Both the trehalose- and carboxybetaine-substituted pCL were further investigated with regard to molecular weight dependence, and it was found that the molecular weight was minimally important for stabilization to refrigeration, but critical for G-CSF stabilization at elevated temperatures. Both high performing zwitterionic and trehalose polyesters were also degraded, and the polymers and degradation products were shown to be noncytotoxic. This work provides potential biocompatible polymers for stabilization of the important therapeutic G-CSF, as well as a general platform for the future discovery of new polymeric protein stabilizers.
许多蛋白质,尤其是那些用作治疗剂的蛋白质,对储存和运输温度不稳定,导致研究和工业成本增加。因此,设计和合成新型稳定剂是一个重要的研究领域。本文报道了新的可降解聚合物,这些聚合物可稳定蛋白质免受冷藏和高温等环境应激源的影响。具体而言,合成了具有不同侧基的聚己内酯,并研究了它们稳定重要治疗性蛋白质储存和运输条件的能力。使用有机催化剂 1,5,7-三氮杂二环[4.4.0]癸-5-烯(TBD)进行烯丙基取代己内酯单体的开环聚合(ROP),得到了一种定义明确的、烯基取代的可降解聚合物,该聚合物用作控制聚合度的通用骨架。通过随后的硫醇-烯反应,引入了相关的侧链,如海藻糖、乳糖、葡萄糖、羧酸甜菜碱和聚(乙二醇)。然后,将这些可降解聚合物用作治疗性蛋白质粒细胞集落刺激因子(G-CSF)的稳定剂,以抵抗在 4°C 和 60°C 的运输温度下储存。用海藻糖和两性离子取代的聚酯观察到最佳的稳定效果。进一步研究了海藻糖和羧酸甜菜碱取代的 pCL 与分子量的依赖性,发现分子量对冷藏时的稳定作用最小,但对高温下 G-CSF 的稳定作用至关重要。表现良好的两性离子和海藻糖聚酯都发生了降解,聚合物和降解产物被证明是非细胞毒性的。这项工作为稳定重要的治疗性 G-CSF 提供了潜在的生物相容聚合物,以及发现新的聚合物蛋白稳定剂的通用平台。